Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 7,007 $ 1,203 $ 16,120 $ 4,732
Operating expenses        
Research and development (33,182) (28,211) (104,674) (81,585)
General and administrative (16,815) (15,173) (48,169) (42,529)
Total operating expenses (49,997) (43,384) (152,843) (124,114)
Operating loss (42,990) (42,181) (136,723) (119,382)
Interest income 324 225 1,019 916
Other (expense) income, net 1,644 (237) 1,001 (184)
Loss before income tax expense (41,022) (42,193) (134,703) (118,650)
Income tax expense (399) (208) (1,503) (582)
Net loss attributable to ordinary shareholders $ (41,421) $ (42,401) $ (136,206) $ (119,232)
Net loss per ordinary share        
Basic (in dollars per share) $ (0.04) $ (0.05) $ (0.14) $ (0.13)
Diluted (in dollars per share) $ (0.04) $ (0.05) $ (0.14) $ (0.13)
Weighted average shares outstanding:        
Basic (in shares) 980,791,114 936,600,648 961,354,122 933,992,708
Diluted (in shares) 980,791,114 936,600,648 961,354,122 933,992,708